Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
R. Servín-Blanco, R. Zamora-Alvarado, G. Gevorkian & K. Manoutcharian. (2016) Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets. Human Vaccines & Immunotherapeutics 12:10, pages 2640-2648.
Read now
Read now
Katie E Lacy, Sophia N Karagiannis & Frank O Nestle. (2012) Immunotherapy for melanoma. Expert Review of Dermatology 7:1, pages 51-68.
Read now
Read now
Jung Seok Kang, Patrick P DeLuca & Kang Choon Lee. (2009) Emerging PEGylated drugs. Expert Opinion on Emerging Drugs 14:2, pages 363-380.
Read now
Read now
Julie A Spicer. (2008) New small-molecule inhibitors of mitogen-activated protein kinase kinase. Expert Opinion on Drug Discovery 3:7, pages 801-817.
Read now
Read now
Vincent G Brichard & Diane Lejeune. (2008) Cancer immunotherapy targeting tumour-specific antigens: towards a new therapy for minimal residual disease. Expert Opinion on Biological Therapy 8:7, pages 951-968.
Read now
Read now
Matthew R Lee, Wei Duan & Seng-Lai Tan. (2008) Protein kinase C isozymes as potential therapeutic targets in immune disorders. Expert Opinion on Therapeutic Targets 12:5, pages 535-552.
Read now
Read now
Andreas Baumann. (2008) Preclinical development of therapeutic biologics. Expert Opinion on Drug Discovery 3:3, pages 289-297.
Read now
Read now
Steve Price & Hazel J Dyke. (2007) Histone deacetylase inhibitors. Expert Opinion on Therapeutic Patents 17:7, pages 745-765.
Read now
Read now
Articles from other publishers (20)
Angelo Aquino, Nicoletta Bianchi, Anna Terrazzan & Ornella Franzese. (2023) Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response. Biology 12:8, pages 1047.
Crossref
Crossref
Siddharth S. Matikonda, Ryan McLaughlin, Pradeep Shrestha, Carol Lipshultz & Martin J. Schnermann. (2022) Structure–Activity Relationships of Antibody-Drug Conjugates: A Systematic Review of Chemistry on the Trastuzumab Scaffold. Bioconjugate Chemistry 33:7, pages 1241-1253.
Crossref
Crossref
Adrian R. Black & Jennifer D. Black. (2021) The complexities of PKCα signaling in cancer. Advances in Biological Regulation 80, pages 100769.
Crossref
Crossref
N. N. Porfiryeva, R. I. Moustafine & V. V. Khutoryanskiy. (2020) PEGylated Systems in Pharmaceutics. Polymer Science, Series C 62:1, pages 62-74.
Crossref
Crossref
Masoud H. Manjili. 2018.
17
36
.
Karel Ulbrich, Kateřina Holá, Vladimir Šubr, Aristides Bakandritsos, Jiří Tuček & Radek Zbořil. (2016) Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies. Chemical Reviews 116:9, pages 5338-5431.
Crossref
Crossref
Drew Pardoll. 2015. The Molecular Basis of Cancer. The Molecular Basis of Cancer
709
738.e8
.
Sarah A. Weiss, Sunandana Chandra & Anna C. Pavlick. (2014) Update on Vaccines for High-Risk Melanoma. Current Treatment Options in Oncology 15:2, pages 269-280.
Crossref
Crossref
Wenjun Li, Peng Zhan, Erik De Clercq, Hongxiang Lou & Xinyong Liu. (2013) Current drug research on PEGylation with small molecular agents. Progress in Polymer Science 38:3-4, pages 421-444.
Crossref
Crossref
Christine Di Cresce, Colin Way, Mateusz Rytelewski, Saman Maleki Vareki, Supritha Nilam, Mark D. Vincent, James Koropatnick & Peter J. Ferguson. 2012. From Nucleic Acids Sequences to Molecular Medicine. From Nucleic Acids Sequences to Molecular Medicine
145
189
.
Suzanne L. TopalianGeorge J. WeinerDrew M. Pardoll. (2011) Cancer Immunotherapy Comes of Age. Journal of Clinical Oncology 29:36, pages 4828-4836.
Crossref
Crossref
Teerapol Srichana & Tan Suwandecha. 2011. Biodegradable Polymers in Clinical Use and Clinical Development. Biodegradable Polymers in Clinical Use and Clinical Development
451
493
.
Jade Homsi, Joshua C. Grimm & Patrick Hwu. (2011) Immunotherapy of Melanoma: An Update. Surgical Oncology Clinics of North America 20:1, pages 145-163.
Crossref
Crossref
Donald J. AbrahamRobert H. Bradbury. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
295
344
.
Motohiko Suzuki, Xiufen Zheng, Xusheng Zhang, Zhu-Xu Zhang, Thomas E. Ichim, Hongtao Sun, Yoshihisa Nakamura, Akira Inagaki, Marianne Beduhn, Aminah Shunnar, Bertha Garcia & Wei-Ping Min. (2010) A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells. Journal of Allergy and Clinical Immunology 125:3, pages 737-743.e6.
Crossref
Crossref
Michal Lotem, Arthur Machlenkin, Tamar Hamburger, Aviram Nissan, Luna Kadouri, Shoshana Frankenburg, Zvi Gimmon, Orit Elias, Inna Ben David, Anna Kuznetz, Eitan Shiloni & Tamar Peretz. (2009) Autologous Melanoma Vaccine Induces Antitumor and Self-Reactive Immune Responses That Affect Patient Survival and Depend on MHC Class II Expression on Vaccine Cells. Clinical Cancer Research 15:15, pages 4968-4977.
Crossref
Crossref
M. Suzuki, X. Zheng, X. Zhang, T. E. Ichim, H. Sun, N. Kubo, M. Beduhn, A. Shunnar, B. Garcia & W.‐P. Min. (2009) Inhibition of allergic responses by CD40 gene silencing. Allergy 64:3, pages 387-397.
Crossref
Crossref
Mark S. Butler. (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Natural Product Reports 25:3, pages 475.
Crossref
Crossref
Drew M. Pardoll. 2008. The Molecular Basis of Cancer. The Molecular Basis of Cancer
649
669
.
David T. Kurtz. 2008. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference
1
5
.